Cortavance (hydrocortisone aceponate) – Conditions or restrictions regarding supply and use - QD07AC
Updated on site: 09-Feb-2018
A. MANUFACTURING AUTHORISATION HOLDER(S) RESPONSIBLE FOR BATCH RELEASE
Name and address of the manufacturer of the biological active substance(s)
Hovione Farmaciencia SA
- Easotic - hydrocortisone aceponate /miconazole nitrate / gentamicin sulphate
Prescription drugs listed. Substance: "Hydrocortisone aceponate"
Name and address of the manufacturer(s) responsible for batch release
1ère Avenue - 2065 m – L.I.D
06516 Carros, France
B. CONDITIONS OR RESTRICTIONS OF THE MARKETING AUTHORISATION REGARDING SUPPLY OR USE
Veterinary medicinal product subject to prescription.
The holder of this marketing authorisation must inform the European Commission about the marketing plans for the medicinal product authorised by this decision.
C. CONDITIONS OR RESTRICTIONS OF THE MARKETING AUTHORISATION WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE PRODUCT
D.STATEMENT OF THE MRLs